Difficulty: Medium
Average Score: 79%
Practice
A physician has a choice in benzodiazepines to prescribe for patients. A particular patient (a 53-year-old man with anxiety) has a difficult time with compliance to medications. The physician is concerned about the patient going into withdrawal because of abrupt discontinuation of the antianxiety medication. Which of the following medications would have the least severe withdrawal reaction?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Diazepam. Diazepam has a long half-life and is metabolized into active metabolites, which results in a more gradual decrease in blood levels when the medication is discontinued. This gradual tapering effect reduces the risk of severe withdrawal symptoms commonly associated with benzodiazepines.
Flurazepam (B), Temazepam (C), and Triazolam (D) have shorter half-lives compared to Diazepam. Abrupt discontinuation of short-acting benzodiazepines like Flurazepam, Temazepam, and Triazolam can lead to more severe withdrawal symptoms due to their rapid elimination from the body, resulting in a sudden drop in blood levels.
Educationally, understanding the pharmacokinetics of benzodiazepines is crucial for healthcare providers to make informed decisions when prescribing these medications, especially for patients with compliance issues. Knowing which benzodiazepines have a longer half-life and are less likely to cause severe withdrawal symptoms upon discontinuation can help prevent adverse outcomes for patients. This knowledge is essential for nurses, pharmacists, and physicians when managing patients on benzodiazepine therapy.
Flurazepam (B), Temazepam (C), and Triazolam (D) have shorter half-lives compared to Diazepam. Abrupt discontinuation of short-acting benzodiazepines like Flurazepam, Temazepam, and Triazolam can lead to more severe withdrawal symptoms due to their rapid elimination from the body, resulting in a sudden drop in blood levels.
Educationally, understanding the pharmacokinetics of benzodiazepines is crucial for healthcare providers to make informed decisions when prescribing these medications, especially for patients with compliance issues. Knowing which benzodiazepines have a longer half-life and are less likely to cause severe withdrawal symptoms upon discontinuation can help prevent adverse outcomes for patients. This knowledge is essential for nurses, pharmacists, and physicians when managing patients on benzodiazepine therapy.